 |
PDBsum entry 6b4d
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Exploring heteroaryl-Pyrazole carboxylic acids as human carbonic anhydrase XII inhibitors.
|
 |
|
Authors
|
 |
R.Cadoni,
N.Pala,
C.Lomelino,
B.P.Mahon,
R.Mckenna,
R.Dallocchio,
A.Dessì,
M.Carcelli,
D.Rogolino,
V.Sanna,
M.Rassu,
C.Iaccarino,
D.Vullo,
C.T.Supuran,
M.Sechi.
|
 |
|
Ref.
|
 |
ACS Med Chem Lett, 2017,
8,
941-946.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
We report the synthesis, biological evaluation, and structural study of a series
of substituted heteroaryl-pyrazole carboxylic acid derivatives. These compounds
have been developed as inhibitors of specific isoforms of carbonic anhydrase
(CA), with potential as prototypes of a new class of chemotherapeutics. Both
X-ray crystallography and computational modeling provide insights into the CA
inhibition mechanism. Results indicate that this chemotype produces an indirect
interference with the zinc ion, thus behaving differently from other related
nonclassical inhibitors. Among the tested compounds, 2c with
Ki = 0.21 μM toward hCA XII demonstrated significant
antiproliferative activity against hypoxic tumor cell lines. Taken together, the
results thus provide the basis of structural determinants for the development of
novel anticancer agents.
|
 |
|
|
|
|
 |